Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-19-028728)

Filing Details

Accession Number:: 0001127602-19-028728
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-18 16:11:39
Reporting Period:: 2019-09-17

Accepted Time:: 2019-09-18 16:11:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1171527	Barton Peter Hutt	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-17	100,000	$0.04	103,924	No	4	M	Direct
Common Stock	Disposition	2019-09-17	100,000	$17.63	3,924	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-09-17	100,000	$0.00	100,000	$0.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
702,752		2022-03-27	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.31 to $17.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.